Komori
Fuso Pharmaceutical Industries (4538) · RiskMaterialised

Securities and Real Estate Price Fluctuation Risk

First written in FY2016. 17 of 28 entries say "Restated". Latest entry: FY2026.

28entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2020-Q1RestatedFY2022 – FY2024-Q1MaterialisedFY2024-Q2 – FY20262016: 320162017: 320172018: 420182019: 420192020: 320202021: 220212022: 120222023: 320232024: 220242025: 120252026: 22026
Same theme, other companies
Risk of Changes in Fair Value and Impairment of Securities, Real Estate and Other AssetsA theme 75 companies write about · 75 as a headwind · 0 as a tailwind

Fuso Pharmaceutical Industries moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.

The whole theme swung hardest in 2019: 24 of 52 companies on the "Worse" side.

27 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 75 companies compared. The sentences above are computed from all 75.
Full recordFilings, disclosures and news, newest first
  1. FY2026MaterialisedAnnual report

    「Loss on valuation of investment securities - 1」

    A loss on valuation of investment securities of ¥1 million was recorded for the fiscal year, and the occurrence of a loss associated with the risk of fluctuations in securities prices was disclosed.
  2. 2026-05-12MaterialisedEarnings

    「Impairment loss on investment securities - 1」

    The company recorded an impairment loss on investment securities of ¥1 million during the fiscal year.
  3. FY2026-H1MaterialisedAnnual report

    「Loss on valuation of investment securities - 1」

    A loss on valuation of investment securities of ¥1 million was recorded as an extraordinary loss for the interim accounting period, resulting in a loss associated with the risk of fluctuations in securities prices.
  4. FY2024MaterialisedAnnual report

    「Loss on valuation of investment securities - 119」

    A loss on valuation of investment securities of ¥119 million was recorded for the fiscal year, resulting in a loss from the risk of fluctuations in securities prices.
  5. FY2024-Q3MaterialisedAnnual report

    「Loss on valuation of investment securities - 110」

    A loss on valuation of investment securities of ¥110 million was recorded as an extraordinary loss for the cumulative third quarter, resulting in a loss associated with the risk of fluctuations in securities prices.
  6. FY2024-Q2MaterialisedAnnual report

    「Loss on valuation of investment securities - 101」

    A loss on valuation of investment securities of ¥101 million was recorded for the cumulative second quarter, resulting in a loss from the risk of fluctuations in securities prices.
  7. FY2024-Q1RestatedAnnual report

    「There were no new major risks during the three months ended 30 June, and no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    No material changes have been identified in the major risks, including fluctuations in the prices of securities and other instruments.
  8. FY2023-Q3RestatedAnnual report

    「During the first three quarters of the current fiscal year, there were no new occurrences of the major risks that management recognises could materially affect the filing company's financial position, operating results or cash flows among the matters relating to business conditions, financial conditions and other matters described in the quarterly report, and no material changes to the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」

    No material changes have been identified in the major risks, including fluctuations in the prices of securities and other instruments.
  9. FY2022RestatedAnnual report

    「We hold assets subject to price fluctuation risks, including securities, and if their prices decline, an impairment loss on investment securities may arise.」

    It continues to describe the risk of impairment losses on investment securities due to declines in securities prices. Real estate remains unmentioned.
  10. FY2021SoftenedAnnual report

    「We hold assets subject to price fluctuation risks, including securities, and if their prices decline, an impairment loss on investment securities may arise.」

    Compared with the previous risk description covering price fluctuations in securities and real estate, the reference to real estate has been removed and the disclosure is now focused on the risk of impairment losses on securities.
  11. FY2021-Q3RestatedAnnual report

    「During the first three quarters of the current fiscal year, there were no new occurrences of the major risks that management recognises could materially affect the filing company's financial position, operating results or cash flows among the matters relating to business conditions, financial conditions and other matters described in the quarterly report, and no material changes to the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」

    It states that there have been no material changes to the key risks, including price fluctuations in securities and real estate.
  12. FY2021-Q2RestatedAnnual report

    「During the cumulative second quarter under review, there were no new major risks that management recognizes could have a material impact on the financial condition, operating results or cash flows of the filing company, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」

    It states that there have been no material changes to the key risks, including price fluctuations in securities and real estate.
  13. FY2020MaterialisedAnnual report

    「Impairment loss on investment securities - 42」

    An impairment loss on investment securities of ¥42 million was recognized during the fiscal year, and losses associated with securities price fluctuation risks materialized for the full year as well.
  14. FY2020-Q3MaterialisedAnnual report

    「Impairment loss on investment securities - 35」

    An impairment loss on investment securities of ¥35 million was recognized as an extraordinary loss for the nine-month period ended in the third quarter, and losses associated with securities price fluctuation risks continue to materialize.
  15. FY2020-Q2MaterialisedAnnual report

    「Valuation loss on investment securities 39」

    For the six-month period ended in the current second quarter, an impairment loss on investment securities of ¥39 million was recognized as an extraordinary loss in the income statement, indicating that losses from securities price fluctuations have materialized.
  16. FY2020-Q1RestatedAnnual report

    「During the cumulative first quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」

    It states that there have been no material changes to business and other risks, including price fluctuations in securities and real estate.
  17. FY2019RestatedAnnual report

    「We hold assets subject to price fluctuation risks, including securities and real estate, which may affect business results and financial position.」

    It continues to describe the risk of price fluctuations in securities and real estate.
  18. FY2019-Q3RestatedAnnual report

    「During the cumulative third quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」

    It states that there have been no material changes to business and other risks, including price fluctuations in securities and real estate.
  19. FY2019-Q2RestatedAnnual report

    「During the cumulative second quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」

    It states that there have been no material changes to business and other risks, including price fluctuations in securities and real estate.
  20. FY2019-Q1RestatedAnnual report

    「During the cumulative first quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」

    It states that there have been no material changes to business and other risks, including price fluctuations in securities and real estate.
  21. FY2018RestatedAnnual report

    「We hold assets subject to price fluctuation risks, including securities and real estate, which may affect business results and financial position.」

    It continues to describe the risk of price fluctuations in securities and real estate.
  22. FY2018-Q3RestatedAnnual report

    「During the cumulative third quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」

    It states that there have been no material changes to business and other risks, including price fluctuations in securities and real estate.
  23. FY2018-Q1RestatedAnnual report

    「During the cumulative first quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」

    It states that there have been no material changes to business and other risks, including price fluctuations in securities and real estate.
  24. FY2017RestatedAnnual report

    「We hold assets subject to price fluctuation risks, including securities and real estate, which may affect business results and financial position.」

    It continues to describe the risk of price fluctuations in securities and real estate.
  25. FY2017-Q3RestatedAnnual report

    「During the cumulative third quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」

    It states that there have been no material changes to the risk of price fluctuations in securities and real estate.
  26. FY2017-Q2RestatedAnnual report

    「During the cumulative second quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」

    It states that there have been no material changes to the risk of price fluctuations in securities and real estate.
  27. FY2017-Q1RestatedAnnual report

    「During the cumulative first quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」

    It states that there have been no material changes to the risks described in the previous fiscal year.
  28. FY2016First statedAnnual report

    「We hold assets subject to price fluctuation risks, including securities and real estate, which may affect business results and financial position.」

    It indicates that price fluctuations in the securities and real estate it holds may affect business results and financial position.
Moved together

"Product Liability Act and Litigation Risks" moved the same way as this thread, in the same document, in 4 of its 28 moves.

42★12
  1. ★This thread
  2. 1Product Liability Act and Litigation Risks4×
  3. 2Uncertainty over the Outlook for the Domestic and Overseas Economies2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Fuso Pharmaceutical Industries yet. It last moved in the Earnings of 2026-05-12: "Materialised".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Securities and Real Estate Price Fluctuation Risk | Fuso Pharmaceutical Industries,Ltd. (4538) | Komori